BR0112261A - Sequenciamento multiplex mediado por transposon - Google Patents
Sequenciamento multiplex mediado por transposonInfo
- Publication number
- BR0112261A BR0112261A BR0112261-4A BR0112261A BR0112261A BR 0112261 A BR0112261 A BR 0112261A BR 0112261 A BR0112261 A BR 0112261A BR 0112261 A BR0112261 A BR 0112261A
- Authority
- BR
- Brazil
- Prior art keywords
- transposon
- sequencing
- multiplex sequencing
- mediated multiplex
- vector
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6806—Preparing nucleic acids for analysis, e.g. for polymerase chain reaction [PCR] assay
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6869—Methods for sequencing
Landscapes
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Analytical Chemistry (AREA)
- Biophysics (AREA)
- Biochemistry (AREA)
- Microbiology (AREA)
- Molecular Biology (AREA)
- Biotechnology (AREA)
- Physics & Mathematics (AREA)
- Genetics & Genomics (AREA)
- Immunology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Saccharide Compounds (AREA)
Abstract
"SEQuENCIAMENTO MULTIPLEX MEDIADO POR TRANSPOSON". A presente invenção refere-se a um método automatizado de seq³enciamento multiplex mediado por transposon de fragmentos de DNA inseridos num vetor. Ela refere-se mais particularmente, a uma maior eficiência em tais métodos automatizados, onde a eficiência aumentada é obtida por seleção antes do seq³enciamento daqueles constructos, nos quais o transposon foi inserido na seq³ência do vetor. Isto evita uma perda de tempo e de recursos na realização de reações de seq³enciamento do vetor em vez de fragmentos de DNA de interesse.
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US21638100P | 2000-07-07 | 2000-07-07 | |
| US60/216,381 | 2000-07-07 | ||
| PCT/US2001/021269 WO2002004674A2 (en) | 2000-07-07 | 2001-07-05 | Transposon mediated multiplex sequencing |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| BR0112261A true BR0112261A (pt) | 2003-09-02 |
| BR0112261B1 BR0112261B1 (pt) | 2012-10-02 |
Family
ID=22806831
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| BRPI0112261-4A BR0112261B1 (pt) | 2000-07-07 | 2001-07-05 | processo para seqüenciamento de dna mediado por transposon, paralelo. |
Country Status (17)
| Country | Link |
|---|---|
| US (1) | US7229798B2 (pt) |
| EP (1) | EP1327000B1 (pt) |
| JP (1) | JP4807921B2 (pt) |
| KR (1) | KR100823857B1 (pt) |
| AR (1) | AR029582A1 (pt) |
| AT (1) | ATE361994T1 (pt) |
| AU (2) | AU2001273185B2 (pt) |
| BR (1) | BR0112261B1 (pt) |
| CA (1) | CA2415786C (pt) |
| DE (1) | DE60128379T2 (pt) |
| IL (2) | IL153797A0 (pt) |
| MX (1) | MXPA03000038A (pt) |
| NO (1) | NO329791B1 (pt) |
| NZ (1) | NZ523507A (pt) |
| TW (1) | TWI235180B (pt) |
| WO (1) | WO2002004674A2 (pt) |
| ZA (1) | ZA200300035B (pt) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2010126356A1 (en) * | 2009-04-29 | 2010-11-04 | Hendrix Genetics B.V. | Method of pooling samples for performing a biological assay |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ATE295427T1 (de) | 1996-06-04 | 2005-05-15 | Univ Utah Res Found | Überwachung der hybridisierung während pcr |
| ATE374821T1 (de) * | 1997-02-20 | 2007-10-15 | Univ Johns Hopkins Med | Mutationen in atp-abhängigen transpositionsproteinen die die zielortspezifität reduzieren |
| WO2000026243A2 (en) * | 1998-10-29 | 2000-05-11 | Incyte Pharmaceuticals, Inc. | Transmembrane 4 proteins |
-
2001
- 2001-07-05 WO PCT/US2001/021269 patent/WO2002004674A2/en active IP Right Grant
- 2001-07-05 EP EP01952433A patent/EP1327000B1/en not_active Expired - Lifetime
- 2001-07-05 MX MXPA03000038A patent/MXPA03000038A/es active IP Right Grant
- 2001-07-05 US US10/332,834 patent/US7229798B2/en not_active Expired - Lifetime
- 2001-07-05 DE DE60128379T patent/DE60128379T2/de not_active Expired - Lifetime
- 2001-07-05 JP JP2002509527A patent/JP4807921B2/ja not_active Expired - Fee Related
- 2001-07-05 KR KR1020037000251A patent/KR100823857B1/ko not_active IP Right Cessation
- 2001-07-05 IL IL15379701A patent/IL153797A0/xx active IP Right Grant
- 2001-07-05 NZ NZ523507A patent/NZ523507A/en not_active IP Right Cessation
- 2001-07-05 AT AT01952433T patent/ATE361994T1/de not_active IP Right Cessation
- 2001-07-05 CA CA002415786A patent/CA2415786C/en not_active Expired - Fee Related
- 2001-07-05 AU AU2001273185A patent/AU2001273185B2/en not_active Ceased
- 2001-07-05 BR BRPI0112261-4A patent/BR0112261B1/pt not_active IP Right Cessation
- 2001-07-05 AU AU7318501A patent/AU7318501A/xx active Pending
- 2001-07-06 TW TW090116787A patent/TWI235180B/zh not_active IP Right Cessation
- 2001-07-06 AR ARP010103238A patent/AR029582A1/es active IP Right Grant
-
2002
- 2002-12-23 NO NO20026206A patent/NO329791B1/no not_active IP Right Cessation
-
2003
- 2003-01-02 ZA ZA200300035A patent/ZA200300035B/en unknown
- 2003-01-05 IL IL153797A patent/IL153797A/en not_active IP Right Cessation
Also Published As
| Publication number | Publication date |
|---|---|
| EP1327000A2 (en) | 2003-07-16 |
| KR100823857B1 (ko) | 2008-04-21 |
| DE60128379D1 (de) | 2007-06-21 |
| JP2004502467A (ja) | 2004-01-29 |
| BR0112261B1 (pt) | 2012-10-02 |
| CA2415786C (en) | 2007-09-25 |
| NO20026206L (no) | 2003-02-25 |
| AU2001273185B2 (en) | 2006-05-18 |
| US20030219779A1 (en) | 2003-11-27 |
| MXPA03000038A (es) | 2003-08-19 |
| ATE361994T1 (de) | 2007-06-15 |
| WO2002004674A3 (en) | 2003-04-17 |
| US7229798B2 (en) | 2007-06-12 |
| KR20030021244A (ko) | 2003-03-12 |
| IL153797A0 (en) | 2003-07-31 |
| IL153797A (en) | 2008-06-05 |
| EP1327000B1 (en) | 2007-05-09 |
| AU7318501A (en) | 2002-01-21 |
| DE60128379T2 (de) | 2008-01-10 |
| TWI235180B (en) | 2005-07-01 |
| ZA200300035B (en) | 2004-03-15 |
| CA2415786A1 (en) | 2002-01-17 |
| NO329791B1 (no) | 2010-12-20 |
| WO2002004674A2 (en) | 2002-01-17 |
| NZ523507A (en) | 2005-01-28 |
| NO20026206D0 (no) | 2002-12-23 |
| AR029582A1 (es) | 2003-07-02 |
| JP4807921B2 (ja) | 2011-11-02 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ATE239090T1 (de) | Methode zum generieren von einzelsträngigen dna molekülen | |
| BR0114887A (pt) | Processos e composições para tratamento de água | |
| ATE468915T1 (de) | Vorrichtung und verfahren zur sequenzierung einer nukleinsäure | |
| DE602004021235D1 (de) | Verfahren, kits und reagenzien zur nukleinsäuresequenzierung | |
| NO20045076L (no) | Fremgangsmate og apparatur for ultralydbehandling av bindevev | |
| DK1178999T3 (da) | L-RIBO-LNA-analoger | |
| IL172093A0 (en) | A plurality of nucleic acid molecules and methods for generating nucleotide sequences | |
| DE60226797D1 (de) | Instrument zum Einbringen von Befestigungselementen für Transplantate | |
| ATE373673T1 (de) | Verbessertes verfahren zur behandlung durch bisulfit | |
| HK1091871A1 (en) | Random array dna analysis by hybridization | |
| DE60114525D1 (de) | Array-basierende Methoden zur Synthese von Nukleinsäuregemischen | |
| ATE525472T1 (de) | Verfahren zur homologen rekombination | |
| TR200003882T2 (tr) | Artropatilerin tedavisi için farnesil protein transferaz inhibitörleri. | |
| EP1921140A4 (en) | MUTANT TRANSPOSON VECTOR AND USE THEREOF | |
| DE60328150D1 (de) | System und Methode zur Erzeugung von Anfangs-Vektoren | |
| ATE462017T1 (de) | Bestimmung der methylierung von nukleinsäuresequenzen | |
| DK1504098T3 (da) | Fremgangsmåde til molekyulær udvikling in vitro af proteinfunktion | |
| BR0112261A (pt) | Sequenciamento multiplex mediado por transposon | |
| ATE468408T1 (de) | Selektive elution von immobilisierten multiplexierten primerverlängerungsprodukten | |
| BR0315178A (pt) | Eritropoietina: remodelagem e glicoconjugação de eritropoietina | |
| NO20045439L (no) | Fremgangsmate og blanding for a behandle fosfat i oppdemte vannmasser | |
| DE60324253D1 (de) | Spezifische multiplex-analyse von nukleinsäuren | |
| DE60204859D1 (de) | Verfahren zur herstellung von 2'-fluoro-beta-l-arabinofuranosylnukleosiden | |
| IL163875A0 (en) | Methods, compositions, and kits for enhancing oli gonucleotide mediated nucleic acid sequence alteration using compositions comprising a histone de | |
| ATE361312T1 (de) | Verfahren zur herstellung von glycopeptid- phosphonat-derivaten |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| B25G | Requested change of headquarter approved |
Owner name: AVENTIS PHARMACEUTICALS, INC. (US) Free format text: SEDE ALTERADA CONFORME SOLICITADO NA PETICAO NO 020070165509/RJ DE 23/11/2007. |
|
| B06F | Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette] | ||
| B06A | Patent application procedure suspended [chapter 6.1 patent gazette] | ||
| B09A | Decision: intention to grant [chapter 9.1 patent gazette] | ||
| B09X | Republication of the decision to grant [chapter 9.1.3 patent gazette] |
Free format text: REF. A RPI NO 2151 DE 27/03/2012. |
|
| B16A | Patent or certificate of addition of invention granted [chapter 16.1 patent gazette] |
Free format text: PRAZO DE VALIDADE: 10 (DEZ) ANOS CONTADOS A PARTIR DE 02/10/2012, OBSERVADAS AS CONDICOES LEGAIS. |
|
| B21F | Lapse acc. art. 78, item iv - on non-payment of the annual fees in time |
Free format text: REFERENTE A 15A ANUIDADE. |
|
| B24J | Lapse because of non-payment of annual fees (definitively: art 78 iv lpi, resolution 113/2013 art. 12) |
Free format text: EM VIRTUDE DA EXTINCAO PUBLICADA NA RPI 2385 DE 20-09-2016 E CONSIDERANDO AUSENCIA DE MANIFESTACAO DENTRO DOS PRAZOS LEGAIS, INFORMO QUE CABE SER MANTIDA A EXTINCAO DA PATENTE E SEUS CERTIFICADOS, CONFORME O DISPOSTO NO ARTIGO 12, DA RESOLUCAO 113/2013. |